Autor: |
Constantin Neagu, Johnson Theresa L, Federica Morandi, Sherer Brian A, Roland Grenningloh, Jared Head, Reinaldo Jones, Hui Qiu, Andreas Goutopoulos, Anna Gardberg, Lesley Liu-Bujalski, Igor Mochalkin, Ariele Viacava Follis, Richard D. Caldwell |
Rok vydání: |
2018 |
Předmět: |
|
Zdroj: |
Bioorganic & Medicinal Chemistry Letters. 28:3419-3424 |
ISSN: |
0960-894X |
DOI: |
10.1016/j.bmcl.2018.09.033 |
Popis: |
Btk is an attractive target for the treatment of a range of Bcell malignancies as well as several autoimmune diseases such as murine lupus and rheumatoid arthritis. Several covalent irreversible inhibitors of Btk are currently in development including ibrutinib which was approved for treatment of B-cell malignancies. Herein, we describe our efforts using X-ray guided structure based design (SBD) to identify a novel chemical series of covalent Btk inhibitors. The resulting pyridine carboxamides were potent and selective inhibitors of Btk having excellent enzymatic and cellular inhibitory activity. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|